K. Daita

发表

Preserved hemostatic status in patients with non-alcoholic fatty liver disease.

A. Sanyal, T. Lisman, M. Siddiqui, 2016, Journal of hepatology.

Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.

H. Nittono, P. Hylemon, J. Bajaj, 2013, Journal of Hepatology.

Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease.

A. Sanyal, T. Lisman, M. Siddiqui, 2017, Thrombosis research.

An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis

G. Rosen, A. Sanyal, M. Contos, 2018, Scientific Reports.

Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.

S. Taylor-Robinson, Roger Williams, I. Cox, 2014, American journal of physiology. Gastrointestinal and liver physiology.

Altered profile of human gut microbiome is associated with cirrhosis and its complications.

Andmorgan R. Fisher, P. Hylemon, A. Sanyal, 2014, Journal of hepatology.

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients

P. Hylemon, J. Bajaj, N. Betrapally, 2016, Alimentary pharmacology & therapeutics.

The Cirrhosis Dysbiosis Ratio defines Changes in the Gut Microbiome Associated with Cirrhosis and its Complications

Andmorgan R. Fisher, P. Hylemon, A. Sanyal, 2014 .

Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.

Masoumeh Sikaroodi, Patrick M Gillevet, Kalyani Daita, 2012, American journal of physiology. Gastrointestinal and liver physiology.

116 THE GUT MICROBIOME MODULATES FECAL BILE ACID PROFILE IN PATIENTS WITH CIRRHOSIS

P. Hylemon, J. Bajaj, J. Ridlon, 2012 .

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis

R. Stravitz, P. Hylemon, A. Sanyal, 2014, Alimentary pharmacology & therapeutics.

The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids

Rohit Kohli, P. Hylemon, A. Sanyal, 2018, Hepatology.

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer

P. Bedossa, Y. Hoshida, S. Koduru, 2016, Journal of hepatology.

Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus

P. Hylemon, J. Bajaj, N. Betrapally, 2015, Scientific Reports.

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

Andmorgan R. Fisher, H. Rangwala, P. Hylemon, 2013, PloS one.

Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy

P. Hylemon, A. Sanyal, J. Bajaj, 2015, Hepatology.

Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis

P. Hylemon, J. Bajaj, N. Betrapally, 2016, Scientific Reports.

Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese[S]

T. Vihervaara, K. Ekroos, A. Sanyal, 2016, Journal of Lipid Research.

An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis

G. Rosen, A. Sanyal, M. Contos, 2018, Scientific Reports.

P0971 : A diet-induced mouse model of nonalcoholic fatty liver disease with progression to advanced fibrosis and hepatocellular carcinoma with a gene expression signature mimicking human disease

P. Bedossa, Y. Hoshida, A. Sanyal, 2015 .

Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density Lipoprotein.

A. Sanyal, F. Mirshahi, M. Fuchs, 2016, Journal of visualized experiments : JoVE.